期刊文献+

五味子醇甲通过调控自噬流减轻大鼠脑缺血再灌注损伤 被引量:7

Schisandrin A attenuates cerebral ischemia-reperfusion injury in rats by regulating autophagic flux
在线阅读 下载PDF
导出
摘要 目的:探究五味子醇甲(Sch A)减轻大鼠脑缺血再灌注损伤的作用及其潜在机制。方法:成年雄性SD大鼠随机分为假手术组(sham组)、模型组[大脑中动脉闭塞(MCAO)组]及Sch A低、中、高剂量治疗组,每组6只。制备大鼠左侧MCAO模型,90 min后再灌注,治疗组Sch A的剂量分别为40、80和160μg·kg^(−1)·d^(−1)。造模7 d后进行神经功能损伤方面的评价(mNSS评分),并用TTC染色检测MCAO大鼠脑梗死体积。通过Western blot检测MCAO大鼠脑缺血半影区神经元自噬相关蛋白P62、LAMP1、cathepsin B和ubiquitin的表达水平,综合分析自噬流情况;使用免疫荧光双标法检测Sch A处理后MCAO大鼠脑缺血半影区神经元自噬水平诱导情况。结果:相比于MCAO组,Sch A处理后大鼠mNSS评分和脑梗死体积显著降低(P<0.05),并有剂量依赖性,以Sch A高剂量组差异显著。Western blot结果显示,与sham组比较,MCAO组大鼠cathepsin B蛋白表达水平下降,P62及ubiquitin的表达水平升高(P<0.05);与MCAO组比较,Sch A处理显著升高cathepsin B表达水平的同时降低了P62及ubiquitin的表达水平,以Sch A高剂量组差异显著(P<0.05);而LAMP1在各组间表达仅有下调或上调趋势,但无显著差异(P>0.05)。免疫荧光结果显示,与MCAO组比较,Sch A处理提高了MCAO大鼠脑缺血半影区LC3-Ⅱ表达阳性的神经元比例,以Sch A高剂量组升高显著(P<0.01)。结论:Sch A可逆转MCAO大鼠脑缺血半影区cathepsin B、P62及ubiquitin表达水平而发挥抗脑缺血再灌注损伤的作用,其机制可能与神经元自噬有关。 AIM:To investigate the protective effect of schisandrin A(Sch A)on the brain of rats with cerebral ischemia-reperfusion injury and its potential mechanism.METHODS:Male SD rats were subjected to left middle cerebral artery occlusion(MCAO)for 90 min before reperfusion.The rats were divided into sham operation group(sham group),model group(MCAO group),low-dose Sch A group,medium-dose Sch A group,and high-dose Sch A group(n=6 in each group).The low,medium and high doses of Sch A were 40,80 and 160μg·kg^(−1)·d^(−1),respectively.The modified neurological severity scores(mNSS)were evaluated after 7 d,and the volume of cerebral infarction was detected by TTC staining.The autophagic flux was assessed by Western blot detection of the expression levels of autophagy-associated proteins P62,LAMP1,cathepsin B and ubiquitin in brain ischemic penumbra neurons.Immunofluorescence double labeling was used to detect the induction of autophagy in the neurons of cerebral ischemic penumbra by Sch A.RESULTS:Compared with MCAO group,the mNSS and cerebral infarction volume of the MCAO rats treated with Sch A were decreased in a dose-dependent manner,with significant difference in high-dose Sch A group(P<0.05).Compared with sham group,the protein expression of cathepsin B in MCAO group was decreased,and the protein expression of P62 and ubiquitin was increased(P<0.05).Compared with MCAO group,the protein expression of cathepsin B was increased significantly after Sch A treatment,while the protein expression of P62 and ubiquitin was decreased,also with significant difference in high-dose Sch A group(P<0.05).The difference of LAMP1 level in each group was not statistically significant(P>0.05).Moreover,the immunofluorescence results showed that compared with MCAO group,the proportion of LC3-Ⅱ positive neurons in the cerebral ischemic penumbra of the rats in Sch A groups was increased,and the increase was significant in high-dose Sch A group(P<0.01).CONCLUSION:Sch A may induce neuronal autophagy in the cerebral ischemic penumbra of SD rats and reverse the expression levels of neuronal autophagy-related proteins cathepsin B,P62 and ubiquitin to protect against cerebral ischemia-reperfusion injury.
作者 臧瑞 郭涛 李旭华 杨继苹 何红云 武煜明 邓仪昊 ZANG Rui;GUO Tao;LI Xu-hua;YANG Ji-ping;HE Hong-yun;WU Yu-ming;DENG Yi-hao(Yunnan University of Chinese Medicine,Kunming 650500,China;Kunming University of Science and Technology,Kunming 650500,China)
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2021年第2期269-276,共8页 Chinese Journal of Pathophysiology
基金 国家自然科学基金项目(No.81860411,No.81960418) 云南省科技计划项目[No.2017FF117(-018),No.2017FF116(-022)]。
关键词 五味子醇甲 脑缺血再灌注损伤 自噬 Schisandrin A Cerebral ischemia-reperfusion injury Autophagy
  • 相关文献

参考文献6

二级参考文献30

  • 1Adams HP Jr, del Zoppo G, Alberts M J, et al. for Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists [ J ]. Stroke,2007, 38(5) :1655-1711.
  • 2del Zoppo GJ, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolie stroke [ J ]. Ann Neurol, 1992,32 ( 1 ) :78-86.
  • 3Mori E, Yoneda Y, Tabuchi M, et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke [ J ]. Neurology, 1992,42 ( 5 ) : 976-982.
  • 4Yamaguchi T, Hayakawa T, Thrombolysis Study Group. Kikuchi H. for the Japanese Intravenous tissue plasminogen activator in acute thromboembolic stroke: a placebocontrolled, double blind trial//del Zoppo GJ, Mori E, Hacke W, eds. Thrombolytic Therapy in Acute Ischemic Stroke ii [ M ]. Heidelberg: Springer-Verlag, 1993: 59-65.
  • 5Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke[J]. N Engl J Med,2008,359(13) :1317-1329.
  • 6Wahlgren N, Ahmed N, Davalos A,et al. Thrombolysis with aheplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST) : an observational study [ J ]. Lancet, 2007,369(9558 ) :275-282.
  • 7Wahlgren N, Ahmed N, Ddvalos A, et al. Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITSISTR) : an observational study [ J ]. Lancet, 2008,372 ( 9646 ) : 1303-1309.
  • 8The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemie stroke [ J ]. N Engl J Med, 1995,333 (24) :1581-1587.
  • 9Clark WM, Albers GW, Madden KP, et al. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A ( A0276g ) : results of a double-blind, placebo-controlled, multicenter study [ J ]. Stroke, 2000, 31 ( 4 ) : 811- 816.
  • 10Clark WM, Wissman S, Albers GW, et al. Recombinant tissue-type plasminogen activator (Aheplase) for ischemic stroke 3 to 5 hours after symptom onset: the ATLANTIS Study: a randomized controlled trial: Aheplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke [ J ]. JAMA, 1999,282 ( 21 ) : 2019-2026.

共引文献40

同被引文献94

引证文献7

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部